Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection

Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection

High levels of macrolide resistance and increasing fluoroquinolone resistance are found in Mycoplasma genitalium in many countries. We evaluated pristinamycin for macrolide-resistant M. genitalium in a sexual health center in Australia. Microbiologic cure was determined by M. genitalium–specific 16S...

Full description

Bibliographic Details
Main Authors: Tim R.H. Read, Jørgen S. Jensen, Christopher K. Fairley, Mieken Grant, Jennifer A. Danielewski, Jenny Su, Gerald L. Murray, Eric P.F. Chow, Karen Worthington, Suzanne M. Garland, Sepehr N. Tabrizi, Catriona S. Bradshaw
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-02-01
Series:Emerging Infectious Diseases
Subjects:
pristinamycin
antimicrobal resistance
Mycoplasma genitalium
nongonococcal urethritis
pelvic inflammatory disease
bacteria
Online Access:https://wwwnc.cdc.gov/eid/article/24/2/17-0902_article

Internet

https://wwwnc.cdc.gov/eid/article/24/2/17-0902_article

Similar Items